Low Levels of Tumor Suppressor Candidate 3 Predict Poor Prognosis of Patients With Hepatocellular Carcinoma

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s153381
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Low Mir-372 Expression Correlates With Poor Prognosis and Tumor Metastasis in Hepatocellular Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

Elevated Levels of Serum Urokinase Plasminogen Activator Predict Poor Prognosis in Hepatocellular Carcinoma After Resection

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Elevated Serum Visfatin Levels Are Associated With Poor Prognosis of Hepatocellular Carcinoma

Oncotarget
Oncology
2017English

Up-Regulation of LINC00161 Correlates With Tumor Migration and Invasion and Poor Prognosis of Patients With Hepatocellular Carcinoma

Oncotarget
Oncology
2017English

Galectin-3 Is Associated With a Poor Prognosis in Primary Hepatocellular Carcinoma

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2014English

Upregulation of E2F Transcription Factor 3 Is Associated With Poor Prognosis in Hepatocellular Carcinoma

Oncology Reports
MedicineCancer ResearchOncology
2014English

Down-Regulation of the Candidate Tumor Suppressor Gene PAR-4 Is Associated With Poor Prognosis in Breast Cancer

International Journal of Oncology
Cancer ResearchOncology
2010English

Impact of Spontaneous Tumor Rupture on Prognosis of Patients With T4 Hepatocellular Carcinoma

Journal of Surgical Oncology
MedicineSurgeryOncology
2016English

Positive Expression of SMYD2 Is Associated With Poor Prognosis in Patients With Primary Hepatocellular Carcinoma

Journal of Cancer
Oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy